Available Technologies

Browse Penn-owned technologies available for licensing.


Search Results - ronald collman

1 Results Sort By:
Monoclonal antibody to CXCR6
CXCR6 is a chemokine receptor expressed by leukocytes and other cells, and is believed to play a role in cancer metastasis, gut mucosal integrity, autoimmunity, diabetes and other inflammatory disorders. It is also used by SIV as a co-receptor for target cell entry. Technology Overview: Current commercially available monoclonal antibodies that...
Published: 1/28/2020   |   Inventor(s): Ronald Collman
Keywords(s): Antibody, Autoimmune, Oncology
Category(s): Research Tools & Reagents